Neil K Warma insider trades: Opexa Therapeutics (OPXA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Neil reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 16, 2014 | OPXA | ↑ Buy | 10,000 | $1.11 | $11K | Direct | Sep 17, 2014 (1d) |
| Jun 14, 2010 | OPXA | ↑ Buy | 8,000 | $1.63 | $13K | Direct | Jun 15, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Neil K Warma's insider trades
Neil K Warma is President, CEO and Acting CFO at Opexa Therapeutics (OPXA). Since Jun 14, 2010, Neil has reported 2 open-market purchases worth $24K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), conversions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPXA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.